Gardasil: first vaccine for human papillomavirus infection

Gardasil is a quadrivalent human papillomavirus vaccine for the prevention of cervical cancer, cervical and vulvar dysplasia and external genital warts. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and Dr Anne Szarewski comments on the implications of the proposed immunisation programme. Copyright © 2007 Wiley Interface Ltd